The company reported healthy operating performance on the back of higher volume, better realization and tight cost control. The revenue/Ebitda/APAT grew by 8%/48% and 760% on YoY basis. The company recorded healthy EBITDA margin of 29% during the quarter driven by sharp contraction in variable cost